Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search


Hostile Environment As Form of Retaliation
October 31, 2003
Can the creation of a hostile environment suffice as an adverse employment action in a retaliation claim under Title VII and in similar state and city actions?
Letter from the Editor
October 28, 2003
A "hello" from our new Editor-in-Chief, Elizabeth Anne "Betiayn" Tursi.
Quiz of the Month
October 27, 2003
Test your knowledge of the law!
The Application of the USA Patriot Act to Private Equity Funds
October 24, 2003
Part one of this article discussed the temporary exemption to the Patriot Act for investment companies and the proposed rule for unregistered investment…
Cameo Clips
October 24, 2003
Copyright Jurisdiction/ Television Licenses The issue of whether a TV programming license was properly terminated is to be decided by a state, rather…
Quiz of the Month
October 22, 2003
Test your knowledge of the law!
Quiz of the Month
October 21, 2003
Test your knowledge of the law!
CA Governor Signs Harshest Anti-Spam Bill in U.S.
October 21, 2003
He may be voted out of office soon, but California Governor Gray Davis is making his mark in the Internet world before he goes. On September 23, Davis signed what to date is the toughest anti-spam bill in the U.S.
Non-Prescription Drug Ad Restructions Eased in UK
October 17, 2003
The latest from the UK.
Counterfeit Drugs: FDA Suggests New Counter Measures
October 16, 2003
<b><i>No 'Magic Bullet,' Says Task Force</i></b> The FDA's Counterfeit Drug Task Force issued its interim report on October 2. It contains potential options for a multi-pronged approach to combat counterfeit drugs. In recent years, the FDA has seen an increase in the number and sophistication of efforts to introduce counterfeit drugs. The FDA noted at the time the report was issued that the problem of counterfeit drugs is being treated separately from the problem of unapproved and potentially unsafe drugs that are being imported via the Internet and other unregulated international channels. Under current law, those drugs are purchased outside of U.S. and foreign consumer protection systems, so they are "buyer beware" products that have traveled outside of the regulatory protections of the legal U.S. drug distribution system.

MOST POPULAR STORIES